Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Proceedings Article
  • Published:

Weighing in on bariatric surgery: who and when?

Abstract

Over two-thirds of the United States is overweight or obese, and over 5% of the country is morbidly obese. Numerous public health preventative measures have been established to help battle this public health epidemic. Surgical obesity treatment, although now gaining popularity, has been an underutilized treatment option for obesity. Patients with a body mass index (BMI) of >40 or >35 kg m−2 with two or more comorbid conditions are eligible for bariatric surgery. Currently, the three most popular bariatric surgeries are Roux-en-y gastric bypass, sleeve gastrectomy and gastric banding procedures, all overwhelmingly performed laparoscopically. The purpose of this article is to discuss the heterogeneity of bariatric surgery. In our practice, among 834 patients operated over a 4-year period (2006–2010), patients were of an average age of 45 years (16–73 years), 80.4% were female patients, 82.5% had private insurance, 61% were White, 17% were Hispanic and 9% were Black. Patients had an average BMI of 46.2 kg m−2 (30.1–75.3 kg m−2), waist circumference of 133.6 cm (68.6–207.8 cm) and four preoperative comorbidities (0–11 comorbidities). Variation exists in surgeon practice patterns for preoperative weight-loss recommendations and complication rates based on surgery case volume. Despite variation in patient, surgeon and hospital characteristics, bariatric surgery outcomes are generally highly safe and effective.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. NIH, NHLBI Obesity Education Initiative. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Available online: http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf.

  2. US Department of Health and Human Services. Overweight and obesity: a major public health issue. Prevent Rep 2001; 16.

  3. Flegal KM, Graubard BI, Williamson DF, Gail MH . Cause-specific excess deaths associated with underweight, overweight, and obesity. J Am Med Assoc 2007; 298: 2028–2037.

    Article  CAS  Google Scholar 

  4. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel HL et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741–752.

    Article  Google Scholar 

  5. Weigle DS . Pharmacological therapy of obesity: past, present, and future. J Clin Endocrinol Metab 2003; 88: 2462–2469.

    Article  CAS  Google Scholar 

  6. Farmer PE, Kim JY . Surgery and global health: a view from beyond the OR. World J Surg 2008; 32: 533–536.

    Article  Google Scholar 

  7. Gastrointestinal surgery for severe obesity: Proceedings of a National Institutes of Health Consensus Development Conference. Am J Clin Nutr 1992; 55 (2 suppl): 487S–619S.

  8. Santry HP, Gillen DL, Lauderdale DS . Trends in bariatric surgical procedures. JAMA 2005; 294: 1909–1917.

    Article  CAS  Google Scholar 

  9. Livingston EH . Procedure incidence and in-hospital complication rates of bariatric surgery in the United States. Am J Surg 2004; 188: 105–110.

    Article  Google Scholar 

  10. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ . Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623–1630.

    Article  Google Scholar 

  11. Leonetti F, Silecchia G, Iacobellis G, Ribaudo MC, Zappaterreno A, Tiberti C et al. Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab 2003; 88: 4227–4231.

    Article  CAS  Google Scholar 

  12. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK . Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008; 247: 401–407.

    Article  Google Scholar 

  13. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005; 15: 1024–1029.

    Article  CAS  Google Scholar 

  14. Stoeckli R, Chanda R, Langer I, Keller U . Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 2004; 12: 346–350.

    Article  CAS  Google Scholar 

  15. Chopra A, Chao E, Etkin Y, Merklinger L, Lieb J, Delany H . Laparoscopic sleeve gastrectomy for obesity: can it be considered a definitive procedure? Surg Endosc 2011; 26: 831–837.

    Article  Google Scholar 

  16. Birkmeyer NJ, Dimick JB, Share D, Hawasli A, English WJ, Genaw J et al. Hospital complication rates with bariatric surgery in Michigan. JAMA 2010; 304: 435–442.

    Article  CAS  Google Scholar 

  17. Flum DR, Salem L, Elrod JA, Dellinger EP, Cheadle A, Chan L . Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA 2005; 294: 1903–1908.

    Article  CAS  Google Scholar 

  18. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Farhbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724–1737.

    Article  CAS  Google Scholar 

  19. Alami RS, Morton JM, Schuster R, Lie J, Sanchez BR, Peters A et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis 2007; 3: 141–145; discussion 145–146.

    Article  Google Scholar 

  20. Van Nieuwenhove Y, Dambrauskas Z, Campillo-Soto A, van Dielen F, Wiezer R, Janssen I et al. Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study. Arch Surg 2011; 146: 1300–1305.

    Article  Google Scholar 

  21. Still CD, Benotti P, Wood GC, Gerhard GS, Petrick A, Reed M et al. Outcomes of preoperative weight loss in high-risk patients undergoing gastric bypass surgery. Arch Surg 2007; 142: 994–998; discussion 999.

    Article  Google Scholar 

  22. Alvarado R, Alami RS, Hsu G, Safadi BY, Sanchez BR, Morton JM et al. The impact of preoperative weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. Obes Surg 2005; 15: 1282–1286.

    Article  CAS  Google Scholar 

  23. Cassie S, Menezes C, Birch DW, Shi X, Karmali S . Effect of preoperative weight loss in bariatric surgical patients: a systematic review. Surg Obes Relat Dis 2011; 7: 760–767; discussion 767.

    Article  Google Scholar 

  24. Woodard GA, Peraza J, Bravo S, Toplosky L, Hernandez-Boussard T, Morton JM . One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs adjustable gastric banding. Obes Surg 2010; 20: 578–582.

    Article  Google Scholar 

  25. Benaiges D, Goday A, Ramon JM, Hernandez E, Pera M, Cano JF . Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis 2011; 7: 575–580.

    Article  Google Scholar 

  26. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307: 56–65.

    Article  Google Scholar 

  27. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753–761.

    Article  CAS  Google Scholar 

  28. Woodard GA, Downey J, Hernandez-Boussard T, Morton JM . Impaired alcohol metabolism after gastric bypass surgery: a case-crossover trial. J Am Coll Surg 2011; 212: 209–214.

    Article  Google Scholar 

Download references

Acknowledgements

Publication of this supplement was partially supported by Nutrilite Health Institute with an unrestricted educational contribution to Stanford Prevention Research Center.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J M Morton.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lodhia, N., Morton, J. Weighing in on bariatric surgery: who and when?. Int J Obes Supp 2 (Suppl 1), S47–S50 (2012). https://doi.org/10.1038/ijosup.2012.12

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijosup.2012.12

Keywords

Search

Quick links